Results 31 to 40 of about 9,178 (186)

Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. [PDF]

open access: yes, 2021
Several tests based on chemiluminescence immunoassay techniques have become available to test for SARS-CoV-2 antibodies. There is currently insufficient data on serology assay performance beyond 35 days after symptoms onset. We aimed to evaluate SARS-CoV-
Ferrara, Francesca   +23 more
core   +3 more sources

Result of the RDT according to the I/O signal in ECLIA test.

open access: yes, 2023
Result of the RDT according to the I/O signal in ECLIA test.
Youssouf Diam Sidibe (14333906)   +15 more
core   +1 more source

Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting?

open access: yesJournal of Public Health Research, 2021
Background: Many laboratories are reporting a numerical cutoff index value (COI) value for most anti-SARS-CoV-2 qualitative tests. These numerical values in patients’ report ultimately created great confusion in the public and physicians, therefore this ...
Shabnum Khawaja   +3 more
doaj   +1 more source

Overall and monthly seroprevalence by type of test (RDT and ECLIA).

open access: yes, 2023
Overall and monthly seroprevalence by type of test (RDT and ECLIA).
Youssouf Diam Sidibe (14333906)   +15 more
core   +1 more source

Evaluation of Performance Characteristics of Enzyme Chemiluminescence Immunoassay (ECLIA) and Rapid Diagnostic Test (RDT) for HBV, HIV and HCV Infections [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: The incidence of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) in India has increased over the past two decades. These infections cause significant mortality and morbidity.
Dipmala Das, Sudipta Roy, Suman Mondal
doaj   +1 more source

Comparison of anti-SARS-CoV-2 antibody titers between samples with false-negative and those with positive ECLIA results.

open access: yes, 2021
SARS-CoV-2 SP IgM (A) and IgG (B) and SARS-CoV-2 NP IgM (C) and IgG (D) antibody titers in blood samples collected from 143 cruise ship crew members who had positive first SARS-CoV-2 genetic test results were measured using ELISA.
Hiroo Hasegawa (3586247)   +16 more
core   +1 more source

Serum thyroglobulin evaluation on LC-MS/MS and immunoassay in TgAb-positive patients with papillary thyroid carcinoma

open access: yesEuropean Thyroid Journal, 2023
Objective: This study aimed to elucidate disproportionately low serum thyroglobulin (Tg) values in Tg antibody (TgAb)-positive patients with structural recurrence of papillary thyroid carcinoma (PTC) using liquid chromatography-tandem mass spectrometry ...
Eijun Nishihara   +9 more
doaj   +1 more source

Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination

open access: yesMalaria Journal, 2020
Background Profiling immune responses induced by either infection or vaccination can provide insight into identification of correlates of protection.
Jessica S. Bolton   +6 more
doaj   +1 more source

Verification and comparison of CLIA with ECLIA immunoassays for determination of procalcitonin [PDF]

open access: yes, 2021
Увод: Верификација клиничко-хемијских метода је од изузетног значаја за обезбеђивање доказа да се карактеристике методе прописане од стране произвођача могу репродуковати у лабораторији где ће се та метода рутински користити.
Bondokić, Kristina, Pešić, Jovana
core   +3 more sources

KESESUAIAN UJI ANTIBODI SARS COV-2 DENGAN METODE ELECTROCHEMILUMINESCENCE IMMUNOASSAY (ECLIA) DAN IMMUNOCHROMATOGRAPHIC TEST (ICT) [PDF]

open access: yes, 2022
Diagnosis laboratorium saat ini didasarkan pada uji molekuler RT-PCR memiliki keterbatasan sensitivitas terutama pada stadium lanjut penyakit. Uji serologi membantu diagnosis COVID-19 dengan mendeteksi antibodi terhadap infeksi SARS CoV-2.
MALFIRA ISWARY
core  

Home - About - Disclaimer - Privacy